July 20, 2009
Pfizer Announces New Phase 1 Data From Two Novel Compounds For…
Main Category: Alzheimer's / Dementia Also Included In: Clinical Trials / Drug Trials Article Date: 16 Jul 2009 Pfizer Inc announced today results from two Phase 1 safety studies, one of PF-04360365, a humanized anti-amyloid monoclonal antibody , and another of dimebon in combination with donepezil HCl tablets, in patients with Alzheimer's …
More: continued here


Leave a Comment
You must be logged in to post a comment.